glp 1 is How long should you take GLP-1 drugs? Study links longer use to lower heart risk How GLP-1 medications are transforming

10.1152/ajpendo.00236.2023

Weight gain is a common consequence of adjuvant treatment for breast cancer ( In this report, both the patients impairment score and limb volume correlated with both weight gain and weight loss

Racing thoughts, physical tension, and an inability to quiet the mind are classic features of anxiety-driven insomnia

Here, we report the design and target validation of EP45, a chimeric dual agonist peptide that has the surprising ability to act as an agonist at both the glucagon-like peptide-1 receptor (GLP-1R) and the neuropeptide Y 2 receptor (NPY2R)

Causes of obesity: a review

Stimulants in Yerba Mate Caffeine : The most abundant stimulant in yerba mate